IVIG-F10

intravenous immunoglobulin · CSL Behring

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IVIG-F10, covering 2011-02-11 to 2011-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID) [Phase 3]

See pricing